Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.
Department of Clinical Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia.
PLoS One. 2023 Jan 24;18(1):e0276277. doi: 10.1371/journal.pone.0276277. eCollection 2023.
Patients suffering from chronic diseases are more likely to experience pDDIs due to older age, prolonged treatment, severe illness and greater number of prescribed drugs. The objective of the current study was to assess the prevalence of pDDIs and risk factors associated with occurrence of pDDIs in chronic disease patients attending outpatient clinics for regular check-ups. Patients suffering from diabetes, chronic obstructive pulmonary disease (COPD), stroke and osteoporosis were included in the study. This study was a cross sectional, observational, prospective study that included 337 patients from outpatient clinics of respiratory ward, cardiac ward and orthopedic ward of Nishter Hospital Multan, Pakistan. The mean number of interactions per patient was 1.68. A greater risk for occurrence of pDDI was associated with older age ≥ 60 years (OR = 1.95, 95% CI = 1.44-2.37, p<0.001); polypharmacy (≥ 5 drugs) (OR = 3.74, 95% CI 2.32-4.54, p<0.001); overburden (OR = 2.23, 95% CI = 1.64-3.16, p<0.01); CCI score (OR = 1.28, 95% CI = 1.04-1.84, p<0.001); multiple prescribers to one patient (OR = 1.18, 95% CI = 1.06-1.41, p<0.01); and trainee practitioner (OR = 1.09, 95% CI = 1.01-1.28, p<0.01). Old age, polypharmacy, overburden healthcare system, higher comorbidity index, multiple prescribers to one patient and trainee practitioner were associated with increased risk of occurrence of pDDIs in chronic disease patients.
患有慢性病的患者由于年龄较大、治疗时间长、病情严重和服用的药物数量较多,更容易发生潜在药物相互作用。本研究的目的是评估慢性病患者在门诊定期检查时发生潜在药物相互作用的患病率和相关风险因素。研究纳入了糖尿病、慢性阻塞性肺疾病(COPD)、中风和骨质疏松症患者。本研究为横断面、观察性、前瞻性研究,纳入了来自巴基斯坦木尔坦尼什特医院呼吸病房、心脏病房和骨科病房的 337 名门诊患者。每位患者的平均相互作用数为 1.68。发生潜在药物相互作用的风险较高与年龄≥60 岁(OR=1.95,95%CI=1.44-2.37,p<0.001);多药治疗(≥5 种药物)(OR=3.74,95%CI 2.32-4.54,p<0.001);负担过重(OR=2.23,95%CI=1.64-3.16,p<0.01);CCI 评分(OR=1.28,95%CI=1.04-1.84,p<0.001);一名患者有多个开方医生(OR=1.18,95%CI=1.06-1.41,p<0.01);和实习医生(OR=1.09,95%CI=1.01-1.28,p<0.01)。年龄较大、多药治疗、医疗保健系统负担过重、较高的合并症指数、一名患者有多个开方医生和实习医生与慢性病患者发生潜在药物相互作用的风险增加相关。